- The 70,000-sq.-ft. Plattsmouth expansion is designed for 5 million kg of annual CreaBoost creatine capacity.
- More than $20 million will fund manufacturing, storage and distribution space while the project adds over 30 Nebraska jobs.
Vireo Systems, a Nashville, Tennessee-based nutraceutical manufacturer and contract manufacturing provider, said Nov. 11 it plans to bring CreaBoost creatine monohydrate production to its Plattsmouth, Nebraska operation. The company will invest more than $20 million in an expansion intended to replace CreaBoost’s reliance on a single international manufacturing partner.
The project will add about 70,000 square feet for manufacturing, storage and distribution. Vireo said the plant is designed for 5 million kg of annual creatine monohydrate capacity and will add more than 30 jobs. Pilot production is targeted for March 2027, with full production planned for the second quarter.
CreaBoost launched its enhanced-purity specification in May 2026 after working with the overseas producer on sourcing, manufacturing and dissolvability. Domestic output is intended to supply U.S. and global markets, initially emphasizing U.S. demand. Vireo already manufactures CON-CRET Creatine HCl in Plattsmouth, and creatine monohydrate is one of its largest production inputs.
Vireo also offers third-party manufacturing across powders, capsules, softgels, liquids and topicals, with services that include formulation, blending, bottling, packaging and copacking. The company said the new investment will use internally reinvested operating cash flow and bank financing. The schedule and 5 million kg capacity remain planned rather than operating figures. CEO and founder Mark Faulkner described the expansion as a supply-chain decision:
“This expansion builds on Vireo’s core focus on vertical integration and controlling our own supply chain as much as possible.”
Mark Faulkner, CEO and founder, Vireo Systems
